LIPOCINE INC. Payments for Restructuring
LIPOCINE INC. (LPCN) reported Payments for Restructuring of $239.57 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2018-03-12
- LIPOCINE INC. payments for restructuring for the quarter ending 2017-12-31 was $23.17K.
- LIPOCINE INC. payments for restructuring for the quarter ending 2017-09-30 was $69.51K.
- LIPOCINE INC. payments for restructuring for the quarter ending 2017-06-30 was $73.14K.
- LIPOCINE INC. payments for restructuring for the quarter ending 2017-03-31 was $73.75K.
- LIPOCINE INC. payments for restructuring for fiscal 2017 was $239.57K, a 45.28% decline from fiscal 2016.
- LIPOCINE INC. payments for restructuring for fiscal 2016 was $437.80K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2017-12-31 | $23.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $92.67K derived: sum of 2 quarters · filed 2018-03-12 | $165.82K derived: sum of 3 quarters · filed 2018-03-12 | $239.57K 10-K · filed 2018-03-12 |
| 2017-09-30 | $69.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $142.65K derived: sum of 2 quarters · filed 2017-11-08 | $216.40K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $73.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $146.90K 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | $73.75K 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | $437.80K 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |